PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Gruber, T. ; Pan, C. ; Contreras, R. ; Wiedemann, T. ; Morgan, D.A.* ; Skowronski, A.A.* ; Lefort, S. ; De Bernardis Murat, C. ; Le Thuc, O. ; Legutko, B. ; Ruiz Ojeda, F.J. ; Fuente-Fernández, M.* ; García-Villalón, A.L.* ; González-Hedström, D.* ; Huber, M. ; Szigeti-Buck, K.* ; Müller, T.D. ; Ussar, S. ; Pfluger, P.T. ; Woods, S.C.* ; Ertürk, A. ; LeDuc, C.A.* ; Rahmouni, K.* ; Granado, M.* ; Horvath, T.L.* ; Tschöp, M.H. ; García-Cáceres, C.

Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension.

Cell Metab. 33, 1155-1170.e10 (2021)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Pathologies of the micro- and macrovascular systems are a hallmark of the metabolic syndrome, which can lead to chronically elevated blood pressure. However, the underlying pathomechanisms involved still need to be clarified. Here, we report that an obesity-associated increase in serum leptin triggers the select expansion of the micro-angioarchitecture in pre-autonomic brain centers that regulate hemodynamic homeostasis. By using a series of cell- and region-specific loss- and gain-of-function models, we show that this pathophysiological process depends on hypothalamic astroglial hypoxia-inducible factor 1α-vascular endothelial growth factor (HIF1α-VEGF) signaling downstream of leptin signaling. Importantly, several distinct models of HIF1α-VEGF pathway disruption in astrocytes are protected not only from obesity-induced hypothalamic angiopathy but also from sympathetic hyperactivity or arterial hypertension. These results suggest that hyperleptinemia promotes obesity-induced hypertension via a HIF1α-VEGF signaling cascade in hypothalamic astrocytes while establishing a novel mechanistic link that connects hypothalamic micro-angioarchitecture with control over systemic blood pressure.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
27.287
5.026
16
39
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Hif1α-vegf ; Angiogenesis ; Astrocytes ; Hypertension ; Hypothalamus ; Leptin ; Obesity; Hypoxia-inducible Factor-1-alpha; Brain Glucose-uptake; Blood-pressure; Insulin-resistance; Arcuate Nucleus; Nerve Activity; Collagen-iv; Leptin; Baroreflex; Neurons
Sprache englisch
Veröffentlichungsjahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 1550-4131
e-ISSN 1932-7420
Zeitschrift Cell Metabolism
Quellenangaben Band: 33, Heft: 6, Seiten: 1155-1170.e10 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort 50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Obesity (IDO)
Institute for Tissue Engineering and Regenerative Medicine (ITERM)
Institute of Diabetes and Cancer (IDC)
POF Topic(s) 90000 - German Center for Diabetes Research
30201 - Metabolic Health
30205 - Bioengineering and Digital Health
Forschungsfeld(er) Helmholtz Diabetes Center
Enabling and Novel Technologies
PSP-Element(e) G-501900-224
G-502200-001
G-505800-001
G-502590-001
G-501900-221
G-502296-001
G-502294-001
Förderungen European Research Council (AdG grant Hypoflam)
German Research Foundation under Germany's Excellence Strategy
Helmholtz Excellence Network
US National Institutes of Health
Department of Veterans Affairs
University of Iowa Fraternal Order of Eagles Diabetes Research Center
Iowa Neuroscience Institute
Technische UniversitaEurot MuEuronchen - Institute for Advanced Study - German Excellence Initiative
European Union Seventh Framework Programme
European Research Council (STG grant AstroNeuroCrosstalk)
German Research Foundation
Marie SklodowskaCurie grant
DOI 10.1016/j.cmet.2021.04.007
WOS ID WOS:000658769700011
PubMed ID 33951475
Erfassungsdatum 2021-06-15
[➜Korrektur melden]